Ipamorelin Research Peptide | Lab Tested | PrecisionsPeptides.com

Real Peptides CJC-1295 (No DAC) + Ipamorelin

Graham — Wed, 17 Jun 2026 22:14:13 +0000

This is a combined research formulation pairing CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue receptor (GHSR) agonist. It is provided as a combined tool preparation for investigating the interaction of complementary GH-axis signaling mechanisms in experimental designs.

This combination has been examined in preclinical in vitro and rodent model studies of pituitary GH secretion dynamics, the additive effects of GHRH and GHSR pathway activation, IGF-1 axis modulation, and pulsatile GH release characterization. The dual-pathway formulation supports comparative mechanistic studies of the GH axis in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides CJC-1295 (No DAC) + Ipamorelin appeared first on PrecisionsPeptides.com.

Catalyst Compounds Ipamorelin

Colten — Wed, 17 Jun 2026 18:28:25 +0000

Ipamorelin is a synthetic pentapeptide that selectively activates the growth hormone secretagogue receptor (GHSR). It is noted in research for prompting growth hormone release while showing limited impact on cortisol and prolactin in animal models.

Experimental designs have used it to study somatotroph signaling, growth hormone pulse characteristics, and IGF-1 axis responses in vitro and in rodents. Its selectivity makes it a clean probe for isolating GHSR-specific activity.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds Ipamorelin appeared first on PrecisionsPeptides.com.

Real Peptides Tesamorelin + Ipamorelin

Graham — Wed, 17 Jun 2026 22:14:11 +0000

This is a combined research formulation pairing Tesamorelin, a stabilized analog of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue receptor (GHSR) agonist. It is provided as a combined tool preparation for investigating the interaction of complementary GH-axis signaling mechanisms in experimental designs.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides Tesamorelin + Ipamorelin appeared first on PrecisionsPeptides.com.

Real Peptides Ipamorelin

Graham — Wed, 17 Jun 2026 22:14:12 +0000

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHSR) agonist. It has been characterized in preclinical research for its selective stimulation of pituitary GH release with minimal observed effect on cortisol, prolactin, or ACTH secretion in rodent model studies, making it a useful tool compound for isolating GH axis endpoints in experimental designs.

Ipamorelin has been used in preclinical in vitro and in vivo models to investigate pituitary GH secretion dynamics, IGF-1 axis modulation, somatotroph cell signaling, and pulsatile GH release characterization. Its relatively short half-life supports time-course experimental designs in cell-based and rodent secretion studies.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides Ipamorelin appeared first on PrecisionsPeptides.com.